About ADNTRO
ADNTRO is a Healthcare company based in Palma (Spain) founded in 2019 by Guillermo Perez Solero. It operates as a saliva-based DNA testing kits are provided for genetic health analysis. ADNTRO has raised $1.1 million across 1 funding round from investors including Bio&Tech Smart Capital. Its website adntro.com draws about 121 thousand monthly visits. ADNTRO offers products and services including DNA Origins Test, Genetic Personality Test, Nutritional Report, and Genetic Test for Intolerances. Its focus areas include HealthTech, Healthcare Booking Platforms, Diagnostics and Internet First Clinical Labs. Its competitors include Made of Genes, Nutricion3g, Genoxage, TellmeGen and DNA Data and 3 more; 2 of its 8 listed competitors have raised funding.
Company details
ADNTRO was founded in 2019 in Palma, Spain, within the genetic testing sector. Saliva-based kits are supplied for analyses related to health, fitness, and nutrition. The process is structured so that kits can be ordered online, saliva samples collected by users, samples forwarded to laboratories for processing, and results delivered via email. Operations focus on direct-to-consumer genetic services in Europe.
- Total Equity Funding$1.1M (USD)
in 1 rounds
- Latest Funding Round$1.1M (USD), Seed
Oct 2024
- Investors
Products & Services of ADNTRO
ADNTRO offers a comprehensive portfolio of products and services, including DNA Origins Test, Genetic Personality Test, Nutritional Report, and Genetic Test for Intolerances.
Analyzes ancestral components and haplogroups for genetic history
Evaluates genetic traits related to personality and behaviors
Offers diet and intolerance recommendations based on genetics
Identifies potential genetic food intolerances and allergies
Apps and channels of ADNTRO
ADNTRO publishes 2 mobile apps with over 5K+ downloads; its YouTube channel ADNTRO GENETICS has 453 subscribers and 30 videos.
Videos from ADNTRO
The most watched videos on ADNTRO's YouTube channel, ADNTRO GENETICS (453 subscribers). Click a video to play it here.
More on ADNTRO GENETICS.
Funding Insights of ADNTRO
ADNTRO has successfully raised a total of $1.1M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.1 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.1M
- Total Rounds 1
- Last Round Seed — $1.1M
- First Round $1.1M
(Oct 2024)
- Investors Count 1
All 1 funding rounds of ADNTRO with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2024 | $1.1M | Seed | – | Bio&Tech Smart Capital | – |
1 investors in total: 1 institutional.
Investors in ADNTRO
ADNTRO has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Bio&Tech Smart Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments in Bio&Tech sectors are facilitated. | – | biotechsmartcapital.com | Santiago de Compostela, Spain |
Investor details for ADNTRO
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ADNTRO
1 people are tracked at ADNTRO (1 in leadership).
| Name | Role | Group |
|---|---|---|
Guillermo Perez Solero | Founder | Leadership |
Complete people profiles for ADNTRO
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ADNTRO
2 dated milestones of ADNTRO across 5 years, from founding to its latest funding, stage changes and deals.
- Founded ADNTRO is founded.
- Funding First funding round of $1.1M.
Competitors of ADNTRO
ADNTRO has 8 listed competitors in our database, 2 of them funded. They include Made of Genes, Nutricion3g, Genoxage, TellmeGen and DNA Data, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| madeofgenes.com | 2015 | Barcelona, Spain | $2.84M | – | Genomics platform for acquiring, storing, and sharing personal genomic information | |
| nutricion3g.es | 2015 | Pamplona, Spain | $21,924 | – | Nutrigenomic testing solutions are provided for nutritional and disease profiling. | |
| genoxage.com | 2012 | Barcelona, Spain | – | – | Provides personalized solutions for managing age-related skin conditions. | |
| tellmegen.com | 2014 | Valencia, Spain | – | – | Genetic diagnostic kits for diseases, traits, and ancestry are supplied. | |
| dnadata.es | 2012 | San Sebastian, Spain | – | – | Genetic and biological analyses are provided for diagnosing genetic diseases. | |
| cresgenomic.com | 2014 | Madrid, Spain | – | – | Delivers comprehensive stem-cell-based regenerative technologies for healthcare challenges. | |
| biogemgx.com | 2023 | Valencia, Spain | – | – | Operates an AI-based platform for genetic testing services. | |
| awsensorsdx.com | 2017 | Valencia, Spain | – | – | Develops DNA diagnostic tools with acoustic resonators for healthcare applications. |
Detailed competitors of ADNTRO
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ADNTRO
The website of ADNTRO (adntro.com) receives about 121.4K visits a month and ranks #219,725 among all websites worldwide, #7,212 in Health.
- Monthly visits121.4K
▼ 20.3% vs previous month
- Unique visitors61.4K
per month
- Global rank#219,725
among all websites
- Category rank#7,212
Health · Health
- Bounce rate40%
- Pages per visit4.1
- Average visit1 min 27 sec
- DevicesDesktop 33% · Mobile 67%
Websites whose visitors overlap most with ADNTRO. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
24genetics.es | 24genetics.es | 100% | – | #2,813,306 | – |
| genotipia.com | 86% | 136K | #328,518 | View details | |
| tellmegen.com | 83% | 226.1K | #153,509 | View details | |
| genomicamedica.com | 81% | 3.5K | #4,934,492 | View details | |
anmm.org.mx | anmm.org.mx | 79% | – | #632,812 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 38 similar websites and full traffic analytics for ADNTRO
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 38 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as ADNTRO (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Adntro
Complete news archive for ADNTRO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ADNTRO
ADNTRO was founded in 2019 and raised its 1st funding round 5 years after it was founded.
ADNTRO is headquartered in Palma, Spain. It is registered at Palma, Balearic Islands, Spain.
ADNTRO is a funded company, having raised a total of $1.1M across 1 funding round to date. The company's 1st funding round was a Seed of $1.1M, raised on Oct 2024.
ADNTRO was founded in 2019 in Palma, Spain, within the genetic testing sector. Saliva-based kits are supplied for analyses related to health, fitness, and nutrition. The process is structured so that kits can be ordered online, saliva samples collected by users, samples forwarded to laboratories for processing, and results delivered via email. Operations focus on direct-to-consumer genetic services in Europe.
ADNTRO's top competitors include Made of Genes, DNA Data and TellmeGen.
ADNTRO offers DNA Origins Test, Genetic Personality Test, Nutritional Report, and Genetic Test for Intolerances.
ADNTRO has 1 investor. Key investors include Bio&Tech Smart Capital.
Yes. ADNTRO publishes ADNTRO GENETICS and 1 more app, with over 5,000 downloads.
The website of ADNTRO receives about 121 thousand visits a month and ranks #219,725 among all websites worldwide.